ClinicalTrials.gov
public full text
Public Domain
Efficacy of Cold-FX (CVT-E002) in the Prevention of Upper Respiratory Tract Infections in Healthy Adults
The purpose of the Study is to determine the prophylactic effects of CVT-E002 treatment for upper respiratory tract infections in healthy adult employees working with residents in continuing care facilities. It is hypothesized that the use of CVT-E002 will effectively reduce the incidence, severity and duration of upper respiratory infections among the participants when compared to placebo.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Evaluate the Potential of Montelukast to Prevent Nasal Symptomatology During Colds#1211651
- Using Automated Calls To Improve Compliance With Acute Coronary Syndrome Best Practice Guidelines#1322269
- Summary of the Prevention of Catheter-Associated Urinary Tract Infection in An Intensive Care Unit#1005176
- Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry#853915
- A Post-marketing Research on Jinyebaidu Granule in Treating Patients With Acute Upper Respiratory Infection#1213186
Record · ID 1295622
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive